[SCHEDULE 13G] Hinge Health, Inc. SEC Filing
Hinge Health, Inc. Schedule 13G filings disclose that several Bessemer-related entities and their general partner hold convertible Class B shares that equal Class A common stock on a 1:1 basis. Deer X Ltd./Deer X LP report ownership of 4,108,707 shares, representing 13.1% of the 27,223,448 Class A-equivalent shares outstanding. Bessemer Venture Partners X L.P. reports 2,119,271 shares (7.2%) and Bessemer Venture Partners X Institutional L.P. reports 1,989,436 shares (6.8%). All reported holdings are sole voting and dispositive power, and percentages are based on the Issuer’s quarterly report as of July 31, 2025. The filings are signed by Scott Ring on behalf of the reporting entities.
Hinge Health, Inc. - i depositi Schedule 13G rivelano che diverse entità legate a Bessemer e il loro socio accomandatario detengono azioni convertibili di Classe B che valgono 1:1 rispetto alle azioni ordinarie di Classe A. Deer X Ltd./Deer X LP dichiarano il possesso di 4.108.707 azioni, pari al 13,1% delle 27.223.448 azioni equivalenti di Classe A in circolazione. Bessemer Venture Partners X L.P. dichiara 2.119.271 azioni (7,2%) e Bessemer Venture Partners X Institutional L.P. 1.989.436 azioni (6,8%). Tutte le detenute sono riportate come potere di voto e di disposizione esclusivi, e le percentuali si basano sul rapporto trimestrale dell’emittente al 31 luglio 2025. I depositi sono firmati da Scott Ring per conto delle entità segnalanti.
Hinge Health, Inc. - los formularios Schedule 13G revelan que varias entidades relacionadas con Bessemer y su socio general poseen acciones convertibles de Clase B que equivalen 1:1 a las acciones ordinarias de Clase A. Deer X Ltd./Deer X LP informan la propiedad de 4.108.707 acciones, que representan el 13,1% de las 27.223.448 acciones equivalentes de Clase A en circulación. Bessemer Venture Partners X L.P. reporta 2.119.271 acciones (7,2%) y Bessemer Venture Partners X Institutional L.P. reporta 1.989.436 acciones (6,8%). Todas las participaciones se declaran con poder de voto y de disposición exclusivos, y los porcentajes se basan en el informe trimestral del emisor al 31 de julio de 2025. Los formularios están firmados por Scott Ring en nombre de las entidades informantes.
Hinge Health, Inc.의 Schedule 13G 제출서에 따르면, Bessemer 관련 여러 법인 및 그 일반 파트너가 클래스 B 전환주를 보유하고 있으며 이는 클래스 A 보통주와 1:1로 산정됩니다. Deer X Ltd./Deer X LP는 4,108,707주를 보유하고 있다고 보고했으며 이는 발행 중인 27,223,448 클래스 A 등가 주식의 13.1%에 해당합니다. Bessemer Venture Partners X L.P.는 2,119,271주(7.2%)를, Bessemer Venture Partners X Institutional L.P.는 1,989,436주(6.8%)를 보고했습니다. 모든 보고된 보유는 단독 의결권 및 처분권을 가진 것으로 기재되어 있으며, 비율은 2025년 7월 31일 기준 발행사의 분기보고서를 기준으로 산정되었습니다. 제출서는 보고 법인을 대표하여 Scott Ring이 서명했습니다.
Hinge Health, Inc. - les dépôts Schedule 13G indiquent que plusieurs entités liées à Bessemer et leur associé commandité détiennent des actions convertibles de Classe B équivalentes 1:1 aux actions ordinaires de Classe A. Deer X Ltd./Deer X LP déclarent détenir 4 108 707 actions, soit 13,1 % des 27 223 448 actions équivalentes de Classe A en circulation. Bessemer Venture Partners X L.P. déclare 2 119 271 actions (7,2 %) et Bessemer Venture Partners X Institutional L.P. 1 989 436 actions (6,8 %). Toutes les participations déclarées disposent du seul pouvoir de vote et de disposition, et les pourcentages sont basés sur le rapport trimestriel de l’émetteur au 31 juillet 2025. Les dépôts sont signés par Scott Ring au nom des entités déclarantes.
Hinge Health, Inc. - aus den Schedule-13G-Meldungen geht hervor, dass mehrere Bessemer-nahe Einrichtungen und ihr General Partner wandelbare Class-B-Aktien halten, die im Verhältnis 1:1 den Class-A-Stammaktien entsprechen. Deer X Ltd./Deer X LP melden den Besitz von 4.108.707 Aktien, was 13,1% der 27.223.448 ausstehenden Class-A-äquivalenten Aktien entspricht. Bessemer Venture Partners X L.P. gibt 2.119.271 Aktien (7,2%) und Bessemer Venture Partners X Institutional L.P. 1.989.436 Aktien (6,8%) an. Alle gemeldeten Bestände werden mit alleinigem Stimm- und Verfügungsrecht angegeben, und die Prozentsätze basieren auf dem Quartalsbericht des Emittenten zum 31. Juli 2025. Die Meldungen sind im Namen der meldenden Stellen von Scott Ring unterzeichnet.
- Transparent disclosure of convertible Class B holdings and exact share counts provides clarity for investors on ownership structure
- Material stakes are clearly quantified: Deer X 4,108,707 shares (13.1%), BVP X 2,119,271 shares (7.2%), BVP X Inst 1,989,436 shares (6.8%)
- No information in this filing about any change in ownership, intent, or planned transactions that would explain the holders’ strategic objectives
- Concentrated ownership (13.1% held by Deer X) could affect corporate governance but the filing does not state any governance intentions
Insights
TL;DR: Major insider-affiliated holders control material voting stakes ranging from 6.8% to 13.1% of Hinge Health’s Class A-equivalent shares.
The Schedule 13G discloses concentrated ownership by Deer X and Bessemer-affiliated funds, each holding Class B shares convertible 1-for-1 into Class A common stock. Deer X’s 13.1% position is a material block that could influence governance depending on board alignment and other holders. The filings show sole voting and dispositive power, indicating direct control over the shares reported. No transactions, pledges, or changes in holdings are described within the provided content; the statement reports positions as of the referenced period and is informational under Rule 13d-1.
TL;DR: Concentrated convertible holdings raise governance significance but this filing is informational, not an activist or change-of-control notice.
The document identifies Deer X and two Bessemer funds as holders of convertible Class B shares that translate to Class A voting power. A single entity (Deer X/GP structure) may be deemed to beneficially own the full 13.1% position, which is material for shareholder voting dynamics. The filing contains no proposals, group formation, or intent statements; it functions as a disclosure of ownership under applicable SEC rules. Materiality stems from the percentage stakes reported rather than any disclosed change in strategy.
Hinge Health, Inc. - i depositi Schedule 13G rivelano che diverse entità legate a Bessemer e il loro socio accomandatario detengono azioni convertibili di Classe B che valgono 1:1 rispetto alle azioni ordinarie di Classe A. Deer X Ltd./Deer X LP dichiarano il possesso di 4.108.707 azioni, pari al 13,1% delle 27.223.448 azioni equivalenti di Classe A in circolazione. Bessemer Venture Partners X L.P. dichiara 2.119.271 azioni (7,2%) e Bessemer Venture Partners X Institutional L.P. 1.989.436 azioni (6,8%). Tutte le detenute sono riportate come potere di voto e di disposizione esclusivi, e le percentuali si basano sul rapporto trimestrale dell’emittente al 31 luglio 2025. I depositi sono firmati da Scott Ring per conto delle entità segnalanti.
Hinge Health, Inc. - los formularios Schedule 13G revelan que varias entidades relacionadas con Bessemer y su socio general poseen acciones convertibles de Clase B que equivalen 1:1 a las acciones ordinarias de Clase A. Deer X Ltd./Deer X LP informan la propiedad de 4.108.707 acciones, que representan el 13,1% de las 27.223.448 acciones equivalentes de Clase A en circulación. Bessemer Venture Partners X L.P. reporta 2.119.271 acciones (7,2%) y Bessemer Venture Partners X Institutional L.P. reporta 1.989.436 acciones (6,8%). Todas las participaciones se declaran con poder de voto y de disposición exclusivos, y los porcentajes se basan en el informe trimestral del emisor al 31 de julio de 2025. Los formularios están firmados por Scott Ring en nombre de las entidades informantes.
Hinge Health, Inc.의 Schedule 13G 제출서에 따르면, Bessemer 관련 여러 법인 및 그 일반 파트너가 클래스 B 전환주를 보유하고 있으며 이는 클래스 A 보통주와 1:1로 산정됩니다. Deer X Ltd./Deer X LP는 4,108,707주를 보유하고 있다고 보고했으며 이는 발행 중인 27,223,448 클래스 A 등가 주식의 13.1%에 해당합니다. Bessemer Venture Partners X L.P.는 2,119,271주(7.2%)를, Bessemer Venture Partners X Institutional L.P.는 1,989,436주(6.8%)를 보고했습니다. 모든 보고된 보유는 단독 의결권 및 처분권을 가진 것으로 기재되어 있으며, 비율은 2025년 7월 31일 기준 발행사의 분기보고서를 기준으로 산정되었습니다. 제출서는 보고 법인을 대표하여 Scott Ring이 서명했습니다.
Hinge Health, Inc. - les dépôts Schedule 13G indiquent que plusieurs entités liées à Bessemer et leur associé commandité détiennent des actions convertibles de Classe B équivalentes 1:1 aux actions ordinaires de Classe A. Deer X Ltd./Deer X LP déclarent détenir 4 108 707 actions, soit 13,1 % des 27 223 448 actions équivalentes de Classe A en circulation. Bessemer Venture Partners X L.P. déclare 2 119 271 actions (7,2 %) et Bessemer Venture Partners X Institutional L.P. 1 989 436 actions (6,8 %). Toutes les participations déclarées disposent du seul pouvoir de vote et de disposition, et les pourcentages sont basés sur le rapport trimestriel de l’émetteur au 31 juillet 2025. Les dépôts sont signés par Scott Ring au nom des entités déclarantes.
Hinge Health, Inc. - aus den Schedule-13G-Meldungen geht hervor, dass mehrere Bessemer-nahe Einrichtungen und ihr General Partner wandelbare Class-B-Aktien halten, die im Verhältnis 1:1 den Class-A-Stammaktien entsprechen. Deer X Ltd./Deer X LP melden den Besitz von 4.108.707 Aktien, was 13,1% der 27.223.448 ausstehenden Class-A-äquivalenten Aktien entspricht. Bessemer Venture Partners X L.P. gibt 2.119.271 Aktien (7,2%) und Bessemer Venture Partners X Institutional L.P. 1.989.436 Aktien (6,8%) an. Alle gemeldeten Bestände werden mit alleinigem Stimm- und Verfügungsrecht angegeben, und die Prozentsätze basieren auf dem Quartalsbericht des Emittenten zum 31. Juli 2025. Die Meldungen sind im Namen der meldenden Stellen von Scott Ring unterzeichnet.